Annual EBITDA
$12.08 B
+$1.43 B+13.38%
31 December 2023
Summary:
GSK annual earnings before interest, taxes, depreciation & amortization is currently $12.08 billion, with the most recent change of +$1.43 billion (+13.38%) on 31 December 2023. During the last 3 years, it has risen by +$1.72 billion (+16.64%). GSK annual EBITDA is now -38.70% below its all-time high of $19.70 billion, reached on 31 December 2015.GSK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$1.52 B
-$1.39 B-47.67%
30 September 2024
Summary:
GSK quarterly earnings before interest, taxes, depreciation & amortization is currently $1.52 billion, with the most recent change of -$1.39 billion (-47.67%) on 30 September 2024. Over the past year, it has dropped by -$1.71 billion (-52.85%). GSK quarterly EBITDA is now -90.43% below its all-time high of $15.92 billion, reached on 31 March 2015.GSK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$8.50 B
-$1.71 B-16.73%
30 September 2024
Summary:
GSK TTM earnings before interest, taxes, depreciation & amortization is currently $8.50 billion, with the most recent change of -$1.71 billion (-16.73%) on 30 September 2024. Over the past year, it has dropped by -$3.53 billion (-29.33%). GSK TTM EBITDA is now -60.84% below its all-time high of $21.70 billion, reached on 31 March 2015.GSK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.4% | -52.9% | -29.3% |
| 3 y3 years | +16.6% | -51.9% | -20.3% |
| 5 y5 years | +23.1% | -54.4% | -32.4% |
GSK EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.4% | -58.2% | +42.7% | -29.3% | at low |
| 5 y | 5 years | at high | +35.4% | -58.2% | +42.7% | -32.4% | at low |
| alltime | all time | -38.7% | -90.4% | +118.0% | -60.8% | +3408.2% |
GSK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.52 B(-47.7%) | $8.50 B(-16.7%) |
| June 2024 | - | $2.91 B(+10.9%) | $10.21 B(-3.5%) |
| Mar 2024 | - | $2.63 B(+82.7%) | $10.58 B(-6.3%) |
| Dec 2023 | $12.08 B(+13.4%) | $1.44 B(-55.5%) | $11.30 B(-6.1%) |
| Sept 2023 | - | $3.23 B(-1.6%) | $12.03 B(+6.0%) |
| June 2023 | - | $3.28 B(-1.7%) | $11.35 B(+7.1%) |
| Mar 2023 | - | $3.34 B(+54.2%) | $10.60 B(-2.8%) |
| Dec 2022 | $10.65 B(+19.4%) | $2.17 B(-15.1%) | $10.90 B(+11.2%) |
| Sept 2022 | - | $2.55 B(+0.6%) | $9.80 B(-5.9%) |
| June 2022 | - | $2.54 B(-30.4%) | $10.41 B(+0.1%) |
| Mar 2022 | - | $3.65 B(+241.4%) | $10.40 B(+8.1%) |
| Dec 2021 | $8.92 B(-13.8%) | $1.07 B(-66.3%) | $9.62 B(-9.7%) |
| Sept 2021 | - | $3.17 B(+25.5%) | $10.66 B(-0.7%) |
| June 2021 | - | $2.52 B(-12.1%) | $10.74 B(-8.8%) |
| Mar 2021 | - | $2.87 B(+36.1%) | $11.78 B(-0.2%) |
| Dec 2020 | $10.35 B(-14.0%) | $2.11 B(-35.0%) | $11.80 B(-2.6%) |
| Sept 2020 | - | $3.24 B(-8.9%) | $12.12 B(-0.8%) |
| June 2020 | - | $3.56 B(+23.0%) | $12.22 B(+5.5%) |
| Mar 2020 | - | $2.89 B(+19.2%) | $11.59 B(-5.1%) |
| Dec 2019 | $12.05 B(+22.8%) | $2.43 B(-27.3%) | $12.21 B(-2.9%) |
| Sept 2019 | - | $3.34 B(+14.1%) | $12.57 B(+1.3%) |
| June 2019 | - | $2.93 B(-16.9%) | $12.40 B(+14.4%) |
| Mar 2019 | - | $3.52 B(+26.3%) | $10.84 B(+11.2%) |
| Dec 2018 | $9.81 B(+22.8%) | $2.79 B(-12.1%) | $9.75 B(+25.7%) |
| Sept 2018 | - | $3.17 B(+132.0%) | $7.76 B(-2.7%) |
| June 2018 | - | $1.37 B(-43.7%) | $7.98 B(-0.5%) |
| Mar 2018 | - | $2.43 B(+205.4%) | $8.02 B(-1.7%) |
| Dec 2017 | $7.98 B(+33.0%) | $795.42 M(-76.5%) | $8.16 B(-8.1%) |
| Sept 2017 | - | $3.39 B(+140.8%) | $8.88 B(+16.1%) |
| June 2017 | - | $1.41 B(-45.1%) | $7.65 B(+15.5%) |
| Mar 2017 | - | $2.56 B(+69.0%) | $6.62 B(+11.9%) |
| Dec 2016 | $6.00 B(-69.5%) | $1.52 B(-29.8%) | $5.92 B(+32.4%) |
| Sept 2016 | - | $2.16 B(+465.2%) | $4.47 B(+4.3%) |
| June 2016 | - | $382.09 M(-79.5%) | $4.28 B(-22.7%) |
| Mar 2016 | - | $1.86 B(+2624.3%) | $5.54 B(-71.7%) |
| Dec 2015 | $19.70 B(+131.8%) | $68.26 M(-96.5%) | $19.60 B(-6.1%) |
| Sept 2015 | - | $1.97 B(+20.3%) | $20.88 B(+0.6%) |
| June 2015 | - | $1.64 B(-89.7%) | $20.75 B(-4.4%) |
| Mar 2015 | - | $15.92 B(+1082.3%) | $21.70 B(+154.5%) |
| Dec 2014 | $8.50 B(-38.3%) | $1.35 B(-27.2%) | $8.53 B(-26.1%) |
| Sept 2014 | - | $1.85 B(-28.5%) | $11.54 B(-13.2%) |
| June 2014 | - | $2.59 B(-5.7%) | $13.30 B(-3.8%) |
| Mar 2014 | - | $2.74 B(-37.1%) | $13.83 B(-4.4%) |
| Dec 2013 | $13.77 B(-1.3%) | $4.36 B(+21.1%) | $14.46 B(+1.4%) |
| Sept 2013 | - | $3.60 B(+15.5%) | $14.26 B(+3.8%) |
| June 2013 | - | $3.12 B(-7.6%) | $13.74 B(+0.0%) |
| Mar 2013 | - | $3.38 B(-18.9%) | $13.74 B(-1.6%) |
| Dec 2012 | $13.95 B(-11.9%) | $4.16 B(+35.1%) | $13.96 B(+6.4%) |
| Sept 2012 | - | $3.08 B(-1.0%) | $13.12 B(-8.9%) |
| June 2012 | - | $3.11 B(-13.5%) | $14.40 B(-3.9%) |
| Mar 2012 | - | $3.60 B(+8.4%) | $14.98 B(-5.5%) |
| Dec 2011 | $15.84 B(+82.8%) | $3.32 B(-23.9%) | $15.85 B(+28.1%) |
| Sept 2011 | - | $4.36 B(+17.9%) | $12.37 B(+3.3%) |
| June 2011 | - | $3.70 B(-17.1%) | $11.98 B(+31.6%) |
| Mar 2011 | - | $4.46 B(-3013.7%) | $9.11 B(+4.7%) |
| Dec 2010 | $8.67 B(-46.0%) | -$153.23 M(-103.9%) | $8.70 B(-35.0%) |
| Sept 2010 | - | $3.97 B(+380.6%) | $13.39 B(-2.1%) |
| June 2010 | - | $825.83 M(-79.6%) | $13.67 B(-17.5%) |
| Mar 2010 | - | $4.06 B(-10.6%) | $16.57 B(+3.1%) |
| Dec 2009 | $16.03 B(-0.7%) | $4.54 B(+6.7%) | $16.06 B(+11.1%) |
| Sept 2009 | - | $4.25 B(+14.4%) | $14.46 B(+1.1%) |
| June 2009 | - | $3.72 B(+4.7%) | $14.30 B(-5.9%) |
| Mar 2009 | - | $3.55 B(+21.1%) | $15.19 B(-6.8%) |
| Dec 2008 | $16.15 B(-12.5%) | $2.93 B(-28.3%) | $16.29 B(-9.8%) |
| Sept 2008 | - | $4.09 B(-11.2%) | $18.06 B(+21.5%) |
| June 2008 | - | $4.61 B(-1.0%) | $14.87 B(+0.7%) |
| Mar 2008 | - | $4.66 B(-0.9%) | $14.76 B(-1.7%) |
| Dec 2007 | $18.46 B(+14.3%) | $4.70 B(+419.2%) | $15.02 B(+13.5%) |
| Sept 2007 | - | $905.16 M(-79.9%) | $13.24 B(-22.8%) |
| June 2007 | - | $4.50 B(-8.4%) | $17.15 B(+2.2%) |
| Mar 2007 | - | $4.91 B(+68.4%) | $16.79 B(+4.3%) |
| Dec 2006 | $16.16 B(+600.6%) | $2.92 B(-39.5%) | $16.09 B(+242.9%) |
| Sept 2006 | - | $4.82 B(+16.4%) | $4.69 B(+20.5%) |
| June 2006 | - | $4.14 B(-1.7%) | $3.89 B(+13.8%) |
| Mar 2006 | - | $4.21 B(-149.7%) | $3.42 B(+21.6%) |
| Dec 2005 | $2.31 B(-81.0%) | -$8.48 B(-310.9%) | $2.81 B(-79.3%) |
| Sept 2005 | - | $4.02 B(+9.7%) | $13.61 B(+5.6%) |
| June 2005 | - | $3.67 B(+1.7%) | $12.89 B(+0.6%) |
| Mar 2005 | - | $3.61 B(+56.0%) | $12.82 B(+2.1%) |
| Dec 2004 | $12.12 B | $2.31 B(-30.1%) | $12.55 B(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2004 | - | $3.31 B(-8.0%) | $12.29 B(-0.3%) |
| June 2004 | - | $3.59 B(+7.5%) | $12.33 B(+1.5%) |
| Mar 2004 | - | $3.34 B(+63.3%) | $12.14 B(+3.0%) |
| Dec 2003 | $11.84 B(+20.6%) | $2.05 B(-38.8%) | $11.79 B(-4.1%) |
| Sept 2003 | - | $3.34 B(-1.9%) | $12.29 B(+10.9%) |
| June 2003 | - | $3.41 B(+14.2%) | $11.08 B(+7.2%) |
| Mar 2003 | - | $2.99 B(+17.2%) | $10.34 B(+5.5%) |
| Dec 2002 | $9.82 B(-1.4%) | $2.55 B(+18.9%) | $9.79 B(-16.6%) |
| Sept 2002 | - | $2.14 B(-19.6%) | $11.75 B(+7.2%) |
| June 2002 | - | $2.66 B(+9.0%) | $10.96 B(+3.0%) |
| Mar 2002 | - | $2.44 B(-45.7%) | $10.64 B(+6.8%) |
| Dec 2001 | $9.96 B(-7.5%) | $4.50 B(+233.0%) | $9.96 B(+5.7%) |
| Sept 2001 | - | $1.35 B(-42.2%) | $9.42 B(-3.2%) |
| June 2001 | - | $2.34 B(+32.5%) | $9.73 B(+3.6%) |
| Mar 2001 | - | $1.77 B(-55.5%) | $9.40 B(-4.1%) |
| Dec 2000 | $10.77 B(+107.5%) | $3.97 B(+138.9%) | $9.80 B(+3945.8%) |
| Sept 2000 | - | $1.66 B(-17.2%) | $242.24 M(-89.1%) |
| June 2000 | - | $2.00 B(-7.6%) | $2.23 B(+53.9%) |
| Mar 2000 | - | $2.17 B(-138.8%) | $1.45 B(-43.6%) |
| Dec 1999 | $5.19 B(-3.0%) | -$5.59 B(-253.4%) | $2.57 B(-16.0%) |
| Sept 1999 | - | $3.65 B(+197.7%) | $3.05 B(+8.8%) |
| June 1999 | - | $1.22 B(-62.7%) | $2.81 B(+2.5%) |
| Mar 1999 | - | $3.29 B(-164.4%) | $2.74 B(+4.1%) |
| Dec 1998 | $5.36 B(-0.5%) | -$5.11 B(-250.1%) | $2.63 B(+10.6%) |
| Sept 1998 | - | $3.40 B(+194.3%) | $2.38 B(+6.6%) |
| June 1998 | - | $1.16 B(-63.7%) | $2.23 B(-48.9%) |
| Mar 1998 | - | $3.18 B(-159.3%) | $4.37 B(-3.5%) |
| Dec 1997 | $5.38 B(-5.6%) | -$5.36 B(-264.7%) | $4.53 B(-35.7%) |
| Sept 1997 | - | $3.25 B(-1.1%) | $7.04 B(-8.0%) |
| June 1997 | - | $3.29 B(-1.4%) | $7.65 B(+1.4%) |
| Mar 1997 | - | $3.34 B(-217.3%) | $7.55 B(+1.1%) |
| Dec 1996 | $5.70 B(+10.9%) | -$2.85 B(-173.6%) | $7.47 B(-27.6%) |
| Sept 1996 | - | $3.87 B(+21.3%) | $10.31 B(+14.5%) |
| June 1996 | - | $3.19 B(-2.1%) | $9.01 B(+1745.6%) |
| Mar 1996 | - | $3.26 B(+27.0%) | $488.17 M(-79.4%) |
| Dec 1995 | $5.14 B(+82.6%) | - | - |
| Sept 1995 | - | $2.56 B(-148.1%) | $2.37 B(+1.4%) |
| June 1995 | - | -$5.33 B(-310.9%) | $2.34 B(-41.0%) |
| June 1995 | $2.82 B(-12.9%) | - | - |
| Mar 1995 | - | $2.53 B(-3.3%) | $3.97 B(+7.2%) |
| Dec 1994 | - | $2.61 B(+3.3%) | $3.70 B(+15.4%) |
| Sept 1994 | - | $2.53 B(-168.3%) | $3.21 B(+15.8%) |
| June 1994 | $3.23 B(+1.7%) | -$3.71 B(-263.9%) | $2.77 B(-14.6%) |
| Mar 1994 | - | $2.26 B(+6.6%) | $3.24 B(+1.0%) |
| Dec 1993 | - | $2.12 B(+1.3%) | $3.21 B(+10.8%) |
| Sept 1993 | - | $2.09 B(-164.8%) | $2.90 B(+8.7%) |
| June 1993 | $3.18 B(+7.5%) | -$3.23 B(-245.0%) | $2.66 B(+5.8%) |
| Mar 1993 | - | $2.23 B(+23.3%) | $2.52 B(+10.9%) |
| Dec 1992 | - | $1.81 B(-2.9%) | $2.27 B(-1.8%) |
| Sept 1992 | - | $1.86 B(-155.1%) | $2.31 B(-0.5%) |
| June 1992 | $2.96 B(+5.6%) | -$3.38 B(-270.5%) | $2.33 B(-41.3%) |
| Mar 1992 | - | $1.98 B(+7.2%) | $3.96 B(+13.4%) |
| Dec 1991 | - | $1.85 B(-1.3%) | $3.49 B(+15.1%) |
| Sept 1991 | - | $1.87 B(-207.3%) | $3.03 B(+19.9%) |
| June 1991 | $2.80 B(+27.6%) | -$1.75 B(-215.4%) | $2.53 B(-0.9%) |
| Mar 1991 | - | $1.51 B(+8.7%) | $2.55 B(+9.2%) |
| Dec 1990 | - | $1.39 B(+1.5%) | $2.34 B(+9.3%) |
| Sept 1990 | - | $1.37 B(-179.5%) | $2.14 B(+9.4%) |
| June 1990 | $2.19 B(+13.6%) | -$1.72 B(-232.7%) | $1.96 B(-20.5%) |
| Mar 1990 | - | $1.30 B(+8.8%) | $2.46 B(+12.8%) |
| Dec 1989 | - | $1.19 B(+0.5%) | $2.18 B(+9.3%) |
| Sept 1989 | - | $1.19 B(-197.3%) | $1.99 B(+9.3%) |
| June 1989 | $1.93 B(+18.9%) | -$1.22 B(-219.8%) | $1.82 B(-9.2%) |
| Mar 1989 | - | $1.02 B(+1.1%) | $2.01 B(+8.3%) |
| Dec 1988 | - | $1.01 B(-1.1%) | $1.85 B(+11.6%) |
| Sept 1988 | - | $1.02 B(-198.4%) | $1.66 B(+10.4%) |
| June 1988 | $1.62 B(+31.1%) | -$1.03 B(-219.8%) | $1.51 B(-10.5%) |
| Mar 1988 | - | $863.72 M(+6.1%) | $1.68 B(+9.7%) |
| Dec 1987 | - | $814.42 M(-5.5%) | $1.53 B(+13.5%) |
| Sept 1987 | - | $862.23 M(-200.4%) | $1.35 B(+16.3%) |
| June 1987 | $1.24 B(+30.1%) | -$858.44 M(-220.2%) | $1.16 B(-7.3%) |
| Mar 1987 | - | $714.30 M(+12.9%) | $1.25 B(+15.9%) |
| Dec 1986 | - | $632.59 M(-6.0%) | $1.08 B(+8.4%) |
| Sept 1986 | - | $672.76 M(-187.7%) | $995.94 M(+15.3%) |
| June 1986 | $951.97 M(>+9900.0%) | -$767.31 M(-241.6%) | $863.62 M(-47.0%) |
| Mar 1986 | - | $542.04 M(-1.2%) | $1.63 B(+49.8%) |
| Dec 1985 | - | $548.45 M(+1.5%) | $1.09 B(+101.5%) |
| Sept 1985 | - | $540.44 M | $540.44 M |
| June 1985 | $0.00(0.0%) | - | - |
| June 1984 | $0.00 | - | - |
FAQ
- What is GSK annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for GSK?
- What is GSK annual EBITDA year-on-year change?
- What is GSK quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for GSK?
- What is GSK quarterly EBITDA year-on-year change?
- What is GSK TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for GSK?
- What is GSK TTM EBITDA year-on-year change?
What is GSK annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GSK is $12.08 B
What is the all time high annual EBITDA for GSK?
GSK all-time high annual earnings before interest, taxes, depreciation & amortization is $19.70 B
What is GSK annual EBITDA year-on-year change?
Over the past year, GSK annual earnings before interest, taxes, depreciation & amortization has changed by +$1.43 B (+13.38%)
What is GSK quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GSK is $1.52 B
What is the all time high quarterly EBITDA for GSK?
GSK all-time high quarterly earnings before interest, taxes, depreciation & amortization is $15.92 B
What is GSK quarterly EBITDA year-on-year change?
Over the past year, GSK quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.71 B (-52.85%)
What is GSK TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GSK is $8.50 B
What is the all time high TTM EBITDA for GSK?
GSK all-time high TTM earnings before interest, taxes, depreciation & amortization is $21.70 B
What is GSK TTM EBITDA year-on-year change?
Over the past year, GSK TTM earnings before interest, taxes, depreciation & amortization has changed by -$3.53 B (-29.33%)